Resolution of Refractory Chronic Autoimmune Thrombocytopenic Purpura Following Mesenchymal Stem Cell Transplantation: A Case Report

Transplantation Proceedings

Volumn 41, Issue 5, 2009, Pages 1827-1830

  Fang, B ^a,b   Song, Y P ^a   Li, N ^a   Li, J ^b   Han, Q ^b   Zhao, R C ^b  

^a Henan Tumor Hospital   (China)

^b Institute of Haematology   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN G; MESNA; VINCRISTINE;

ADIPOSE TISSUE; ADULT; ARTICLE; CASE REPORT; HUMAN; HUMAN CELL; IMMUNOLOGICAL TECHNIQUE; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MYELODYSPLASTIC SYNDROME; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; RELAPSE; REMISSION; SPLENECTOMY; T CELL DEPLETION; THROMBOCYTE COUNT; THROMBOCYTOPENIC PURPURA; TREATMENT RESPONSE;

GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; INFUSIONS, INTRAVENOUS; LEUKOCYTE COUNT; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; NEUTROPHILS; PLATELET COUNT; PURPURA; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; YOUNG ADULT;

EID: 67449126355     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.12.031     Document Type: Article

References (36)

1. McMillan R. Autoantibodies and autoantigens in chronic immune thrombocytopenic purpura. Semin Hematol 37 (2000) 239
2. Beardsley D.S., and Ertem M. Platelet autoantibodies in immune thrombocytopenic purpura. Transfus Sci 19 (1998) 237
3. Kiefel V., Freitag E., Kroll H., et al. Platelet autoantibodies (IgG, IgM, IgA) against glycoproteins IIb/IIIa and Ib/IX in patients with thrombocytopenia. Ann Hematol 72 (1996) 280
4. Fujisawa K., Tani P., Piro L., et al. The effect of therapy on platelet-associated autoantibody in chronic immune thrombocytopenic purpura. Blood 81 (1993) 2872
5. George J.N., and Raskob G.E. Idiopathic thrombocytopenic purpura: a concise summary of the pathophysiology and diagnosis in children and adults. Semin Hematol 35 1 suppl 1 (1998) 5
6. Diehl L.F., and Ketchum L.H. Autoimmune disease and chronic lymphocytic leukemia: autoimmune hemolytic anemia, pure red cell aplasia, and autoimmune thrombocytopenia. Semin Oncol 25 (1998) 80
7. Jolles S., Sewell W.A., and Misbah S.A. Clinical uses of intravenous immunoglobulin. Clin Exp Immunol 142 (2005) 1
8. Kumar S., Diehn F.E., Gertz M.A., et al. Splenectomy for immune thrombocytopenic purpura: long-term results and treatment of postsplenectomy relapses. Ann Hematol 81 (2002) 312
9. Semple J.W., Lazarus A.H., and Freedman J. The cellular immunology associated with autoimmune thrombocytopenic purpura: an update. Transfus Sci 19 (1998) 245
10. Kuwana M., Kaburaki J., Ikeda Y., et al. Autoreactive T cells to platelet GPIIb-IIIa in immune thrombocytopenic purpura. Role in production of anti-platelet autoantibody. J Clin Invest 102 (1998) 1393
11. Marmont A.M., van Lint M.T., Occhini D., et al. Failure of autologous stem cell transplantation in refractory thrombocytopenic purpura. Bone Marrow Transplant 22 (1998) 827
12. Huhn R.D., Fogarty P.F., Nakamura R., et al. High-dose cyclophosphamide with autologous lymphocyte-depleted peripheral blood stem cell (PBSC) support for treatment of refractory chronic autoimmune thrombocytopenia. Blood 101 (2003) 71
13. Elli E., Parma M., Perseghin P., et al. Successful treatment with T-depleted autologous peripheral blood stem cell transplantation of refractory chronic autoimmune thrombocytopenic purpura. Haematologica 92 (2007) e7
14. Lim S.H., Kell J., al-Sabah A., et al. Peripheral blood stem-cell transplantation for refractory autoimmune thrombocytopenic purpura. Lancet 349 (1997) 475
15. Skoda R.C., Tichelli A., Tyndall A., et al. Autologous peripheral blood stem cell transplantation in a patient with chronic autoimmune thrombocytopenia. Br J Haematol 99 (1997) 56
16. Chen X., Armstrong M.A., and Li G. Mesenchymal stem cells in immunoregulation. Immunol Cell Biol 84 (2006) 413
17. Le Blanc K., and Ringdén O. Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 11 (2005) 321
18. Bartholomew A., Sturgeon C., Siatskas M., et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 30 (2002) 42
19. Tse W.T., Pendleton J.D., Beyer W.M., et al. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 75 (2003) 389
20. Fang B., Song Y.P., Liao L.M., et al. Treatment of severe therapy-resistant acute graft-versus-host disease with human adipose tissue-derived mesenchymal stem cells. Bone Marrow Transplant 38 (2006) 389
21. Krampera M., Glennie S., Dyson J., et al. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 101 (2003) 3722
22. Deng W., Han Q., Liao L., et al. Effects of allogeneic bone marrow-derived mesenchymal stem cells on T and B lymphocytes from BXSB mice. DNA Cell Biol 24 (2005) 458
23. Corcione A., Benvenuto F., Ferretti E., et al. Human mesenchymal stem cells modulate B-cell functions. Blood 107 (2006) 367
24. Koç O.N., Gerson S.L., Cooper B.W., et al. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol 18 (2000) 307
25. Fang B., Song Y., Lin Q., et al. Human adipose tissue-derived mesenchymal stromal cells as salvage therapy for treatment of severe refractory acute graft-vs.-host disease in two children. Pediatr Transplant 11 (2007) 814
26. Lazarus H.M., Haynesworth S.E., Gerson S.L., et al. Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use. Bone Marrow Transplant 16 (1995) 557
27. Ringdén O., Uzunel M., Rasmusson I., et al. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation 81 (2006) 1390
28. Lazarus H.M., Koc O.N., Devine S.M., et al. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant 11 (2005) 389
29. Le Blanc K., Tammik L., Sundberg B., et al. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 57 (2003) 11
30. McMillan R. Therapy for adults with refractory chronic immune thrombocytopenic purpura. Ann Intern Med 126 (1997) 307
31. Bierings M. The role of T-cell depletion of autografts for autoimmune diseases. Rheumatology (Oxford) 38 (1999) 755
32. Le Blanc K., Rasmusson I., Sundberg B., et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363 (2004) 1439
33. Zappia E., Casazza S., Pedemonte E., et al. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 106 (2005) 1755
34. Aggarwal S., and Pittenger M.F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105 (2005) 1815
35. Jiang X.X., Zhang Y., Liu B., et al. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood 105 (2005) 4120
36. Beyth S., Borovsky Z., Mevorach D., et al. Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 105 (2005) 2214